NCT06660199 Text-based Support for Parents of Adolescents Following an Emergency Department Visits
| NCT ID | NCT06660199 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Suicide |
| Study Type | INTERVENTIONAL |
| Enrollment | 420 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 420 participants in total. It began in 2025-12-01 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to determine the effectiveness of an adaptive text-based intervention for parents of adolescents seeking emergency department services for suicide risk concerns.
Eligibility Criteria
Inclusion Criteria: * Adolescent (13-17 years old) who present to Emergency Department (ED) due to (1) last-week suicidal ideation and/or (2) last-month suicide attempt, and their caregiver. Exclusion Criteria: Adolescents who are: * medically unstable * presenting with severe cognitive impairment, altered mental status, severe aggression/agitation * presenting without a legal guardian * whose parent does not own a cell phone
Contact & Investigator
Ewa Czyz, Ph.D.
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT06660199 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, studying Suicide. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06660199 currently recruiting?
Yes, NCT06660199 is actively recruiting participants. Contact the research team at ewac@umich.edu for enrollment information.
Where is the NCT06660199 trial being conducted?
This trial is being conducted at Ann Arbor, United States, Flint, United States.
Who is sponsoring the NCT06660199 clinical trial?
NCT06660199 is sponsored by University of Michigan. The principal investigator is Ewa Czyz, Ph.D. at University of Michigan. The trial plans to enroll 420 participants.